Status:
TERMINATED
Nitrous Oxide for PTSD
Lead Sponsor:
VA Office of Research and Development
Conditions:
PTSD
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
Post-traumatic stress disorder (PTSD) seriously disrupts the lives of many Veterans. Current first-line treatments, serotonin reuptake inhibitors or prolonged exposure therapy, take weeks to months to...
Detailed Description
The proposed projects will examine the efficacy of nitrous oxide in relieving Veteran's PTSD symptoms and in parallel, explore whether nitrous oxide improves cognitive and pain outcomes. Specifically,...
Eligibility Criteria
Inclusion
- Veteran
- primary diagnosis of PTSD
- sufficient severity of PTSD symptoms
- capacity to provide informed consent
Exclusion
- psychiatric or medical conditions that make participation unsafe
- pregnant or nursing females
- concurrent use of any medications that might increase the risk of participation (e.g. drug interactions
Key Trial Info
Start Date :
October 7 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2022
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT04378426
Start Date
October 7 2021
End Date
August 31 2022
Last Update
March 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Palo Alto Health Care System, Palo Alto, CA
Palo Alto, California, United States, 94304-1290